Royal Surrey NHS Foundation Trust Pioneers New Heart Disease Treatment

The Royal Surrey NHS Foundation Trust is spearheading a novel treatment for individuals diagnosed with coronary artery disease. It has become the inaugural NHS trust within the UK to implement Medis-QFR (Quantitative Flow Ratio) technology. This technology offers a non-surgical method for assessing blood circulation to a patient’s heart, providing a non-interventional diagnostic option for those who require it. The introduction of this innovative treatment follows the refurbishment of the trust’s cardiac catheterisation laboratory, which was completed over a year ago. Patients presenting with blocked or narrowed coronary arteries typically undergo a coronary angiogram, a procedure utilizing X-ray and a specialized dye to visualize obstructions in the heart’s vessels. However, a subsequent invasive procedure is usually necessary to determine if the narrowing is causing issues with blood flow. Dr. Alvina Amin, the clinical director for cardiology, stated: “We are incredibly proud to be one of the first centres offering this advanced investigation. It highlights our unwavering commitment to advancing patient care through innovation. This milestone marks a significant continuation of our journey toward delivering the most advanced cardiology services available, setting new standards in patient care both nationally and internationally.”